braftovi hard capsule 50mg
pierre fabre singapore pte ltd - encorafenib - capsule - encorafenib 50mg
braftovi hard capsule 75mg
pierre fabre singapore pte ltd - encorafenib - capsule - encorafenib 75mg
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastic agents - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy
braftovi capsule
pfizer canada ulc - encorafenib - capsule - 75mg - encorafenib 75mg - antineoplastic agents